These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 10463571

  • 1. FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease.
    Campiglio M, Pekarsky Y, Menard S, Tagliabue E, Pilotti S, Croce CM.
    Cancer Res; 1999 Aug 15; 59(16):3866-9. PubMed ID: 10463571
    [Abstract] [Full Text] [Related]

  • 2. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Muñoz N, Bosch FX, Shah K, Cho KR.
    Cancer Res; 1997 Nov 01; 57(21):4692-8. PubMed ID: 9354423
    [Abstract] [Full Text] [Related]

  • 3. The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma.
    Gatalica Z, Lele SM, Rampy BA, Norris BA.
    Cancer; 2000 Mar 15; 88(6):1378-83. PubMed ID: 10717620
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M, Wistuba II, Fong KM, Behrens C, Kodagoda DR, Saboorian MH, Shay J, Tomlinson GE, Blum J, Minna JD, Gazdar AF.
    Cancer Res; 1997 Sep 01; 57(17):3664-8. PubMed ID: 9288768
    [Abstract] [Full Text] [Related]

  • 5. Study of FHIT transcripts in normal and malignant breast tissue.
    Bièche I, Latil A, Becette V, Lidereau R.
    Genes Chromosomes Cancer; 1998 Dec 01; 23(4):292-9. PubMed ID: 9824201
    [Abstract] [Full Text] [Related]

  • 6. The Fragile Histidine Triad gene and breast cancer.
    Yang Q, Yoshimura G, Sakurai T, Kakudo K.
    Med Sci Monit; 2002 Jul 01; 8(7):RA140-4. PubMed ID: 12118213
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
    Capuzzi D, Santoro E, Hauck WW, Kovatich AJ, Rosato FE, Baffa R, Huebner K, McCue PA.
    Cancer; 2000 Jan 01; 88(1):24-34. PubMed ID: 10618602
    [Abstract] [Full Text] [Related]

  • 13. Loss of FHIT expression in gastric carcinoma.
    Baffa R, Veronese ML, Santoro R, Mandes B, Palazzo JP, Rugge M, Santoro E, Croce CM, Huebner K.
    Cancer Res; 1998 Oct 15; 58(20):4708-14. PubMed ID: 9788626
    [Abstract] [Full Text] [Related]

  • 14. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).
    Zou TT, Lei J, Shi YQ, Yin J, Wang S, Souza RF, Kong D, Shimada Y, Smolinski KN, Greenwald BD, Abraham JM, Harpaz N, Meltzer SJ.
    Oncogene; 1997 Jul 03; 15(1):101-5. PubMed ID: 9233782
    [Abstract] [Full Text] [Related]

  • 15. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
    Bugert P, Wilhelm M, Kovacs G.
    Genes Chromosomes Cancer; 1997 Sep 03; 20(1):9-15. PubMed ID: 9290948
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
    Yang Q, Yoshimura G, Suzuma T, Tamaki T, Umemura T, Nakamura M, Nakamura Y, Wang X, Mori I, Sakurai T, Kakudo K.
    Clin Cancer Res; 2001 Dec 03; 7(12):3869-73. PubMed ID: 11751477
    [Abstract] [Full Text] [Related]

  • 17. Loss of Msh2 is not associated with FHIT deletion in breast carcinomas.
    Yang Q, Nakamura Y, Nakamura M, Yoshimura G, Suzuma T, Umemura T, Mori I, Sakurai T, Kakudo K.
    Anticancer Res; 2002 Dec 03; 22(5):2591-5. PubMed ID: 12529969
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
    Gayther SA, Barski P, Batley SJ, Li L, de Foy KA, Cohen SN, Ponder BA, Caldas C.
    Oncogene; 1997 Oct 23; 15(17):2119-26. PubMed ID: 9366528
    [Abstract] [Full Text] [Related]

  • 20. Loss of Fhit protein expression in high-grade and advanced stage endometrial carcinomas.
    Yura Y, Mandai M, Konishi I, Hamid AA, Tsuruta Y, Kusakari T, Fujii S.
    Anticancer Res; 2003 Oct 23; 23(3C):2837-43. PubMed ID: 12926121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.